Novel Acinetobacter baumannii Myovirus TaPaz Encoding Two Tailspike Depolymerases: Characterization and

Anastasia S Shchurova1,2, Mikhail M Shneider3, Nikolay P Arbatsky4

  • 1Moscow Institute of Physics and Technology (National Research University), Institutskiy per. 9, Dolgoprudny, 141700 Moscow Region, Russia.

Viruses
|June 2, 2021
PubMed

Insights

A novel bacteriophage, TaPaz, was isolated and studied. Its tailspike depolymerases show potential for targeting specific Acinetobacter baumannii capsular polysaccharide types, offering new avenues for combating this nosocomial pathogen.

Area of Science:

  • Microbiology
  • Virology
  • Biochemistry

Background:

  • Acinetobacter baumannii is a major cause of hospital-acquired infections.
  • Bacteriophages targeting A. baumannii are crucial for controlling infections.
  • Capsular polysaccharides (CPSs) are key receptors for bacteriophages and influence bacterial virulence.

Purpose of the Study:

  • To characterize the novel myovirus TaPaz infecting A. baumannii.
  • To investigate the genomic organization and host interaction strategies of TaPaz.
  • To identify and evaluate the function of TaPaz's polysaccharide-degrading enzymes.

Main Methods:

  • Isolation and characterization of bacteriophage TaPaz.
  • Genome sequencing and analysis of TaPaz.
  • Purification and biochemical testing of recombinant tailspike depolymerases (TSDs).

Main Results:

  • TaPaz possesses a 93,703 bp double-stranded DNA genome with 178 open reading frames.
  • Two distinct tailspike depolymerase genes were identified within the TaPaz genome.
  • One recombinant TSD specifically cleaved the K47 capsular polysaccharide of A. baumannii via hydrolysis.

Conclusions:

  • The novel myovirus TaPaz offers insights into A. baumannii-phage interactions.
  • TaPaz encodes specific polysaccharide-degrading enzymes with potential therapeutic applications.
  • The characterized tailspike depolymerase demonstrates targeted activity against K47 A. baumannii strains.